| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Oncology and Immunology, Nippon Roche Research Center, 200 Kajiwara, Kamakura City, Kanagawa-247, Japan
Murine colon 26 adenocarcinoma causes a progressive weight loss and physiological changes associated with cachexia when it grows to a certain size. By the use of this tumor model several types of cytostatics were examined for their ability to alleviate cachexia. Among them, 5'-deoxy-5-fluorouridine could reverse a progressive weight loss and improve hypoglycemia, hyperglucocorticism, and hepatic malfunctions, as well as inhibiting the tumor growth. Cyclophosphamide, nimustine, and 2'-deoxy-5-fluorouridine were only slightly effective in reversing the wasting, while 5-fluorouridine, tegafur, mitomycin C, cis-platinum, and doxorubicin were not active. Within 3 days after 5'-deoxy-5-fluorouridine was administered to cachectic mice with large tumor burdens, the wasting was immediately reversed even at doses in which there was increase or no significant reduction in tumor growth. These results indicate that the anticachectic activity of 5'-deoxy-5-fluorouridine is independent of its antiproliferative activity.
1 To whom requests for reprints should be addressed.
Received 10/18/89.
Revised 4/ 9/90.
This article has been cited by other articles:
|
|
 |
|
  Y.-J. Nai, Z.-W. Jiang, Z.-M. Wang, N. Li, and J.-S. Li Prevention of Cancer Cachexia by Pyrrolidine Dithiocarbamate (PDTC) in Colon 26 Tumor-Bearing Mice JPEN J Parenter Enteral Nutr, January 1, 2007; 31(1): 18 - 25. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Chandra, G. W. Kabalka, D. R. Lorey II, D. R. Smith, and J. A. Coderre Imaging of Fluorine and Boron from Fluorinated Boronophenylalanine in the Same Cell at Organelle Resolution by Correlative Ion Microscopy and Confocal Laser Scanning Microscopy Clin. Cancer Res., August 1, 2002; 8(8): 2675 - 2683. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Tilignac, S. Temparis, L. Combaret, D. Taillandier, M.-N. Pouch, M. Cervek, D. M. Cardenas, T. Le Bricon, E. Debiton, S. E. Samuels, et al. Chemotherapy Inhibits Skeletal Muscle Ubiquitin-Proteasome-dependent Proteolysis Cancer Res., May 1, 2002; 62(10): 2771 - 2777. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Inui Cancer Anorexia-Cachexia Syndrome: Current Issues in Research and Management CA Cancer J Clin, March 1, 2002; 52(2): 72 - 91. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Yoshida, Y. Maehara, and K. Sugimachi MST-16, a Novel Bis-dioxopiperazine Anticancer Agent, Ameliorates Doxorubicin-induced Acute Toxicity While Maintaining Antitumor Efficacy Clin. Cancer Res., December 1, 1999; 5(12): 4295 - 4300. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Villalona-Calero, G. R. Weiss, H. A. Burris, M. Kraynak, G. Rodrigues, R. L. Drengler, S. G. Eckhardt, B. Reigner, J. Moczygemba, H. U. Burger, et al. Phase I and Pharmacokinetic Study of the Oral Fluoropyrimidine Capecitabine in Combination With Paclitaxel in Patients With Advanced Solid Malignancies J. Clin. Oncol., June 1, 1999; 17(6): 1915 - 1915. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
